Analysis and modeling for calculation the need for x-ray therapy systems in Tajikistan
Abstract
Every year in the Republic of Tajikistan, more than 3,000 patients are diagnosed with cancer. The geographical location of Tajikistan with high insolation in the region is a key risk factor for skin cancer. X-ray therapy is successfully used for the treatment of non-melanoma skin cancer, and other oncological and non-oncological diseases. To date, the calculation of the need for X-ray therapy systems has not been carried out.
Objective: to analyze the needs of the Republic of Tajikistan in radiotherapy equipment. Material and research methods: methods of bibliographic and information search, semantic search, analysis of scientific literature and normative legal acts, economic method of mathematical modeling.
Results of the study and their discussion. The need for radiotherapy devices for Tajikistan can be calculated in three ways: “by the number of the population served” 12 devices, “by the number of oncological dispensaries in the country” 5 units, “by oncological morbidity” (Lean management approach) one system. The proposed models should be adjusted taking into account the territorial accessibility of the method for the population, current clinical recommendations, as well as the availability of other radiotherapy equipment.
Conclusion. X-ray therapy is of particular interest to the organization of oncological care due to the low cost of devices in comparison with other radiotherapy equipment, as well as the low cost of their maintenance, high operational efficiency and ease of use. Heads of medical institutions need to know different approaches to calculate the needs.
About the Author
Yu. A. Zuenkova
Peoples Friendship University of Russia (RUDN University)
Tajikistan
Tajikistan
Doctor of business administration, high-school teacher of the department health care organization, pharmacy provision, medical technologies and hygiene.
6 Miklukho-Maklaya str., Moscow 117198
References
1. Hamouzadeh P., Darkhor S., Aboie P., Zare M., & Gray S. Safety and Effectiveness of Superficial Radiation Therapy in the Treatment of Skin Diseases: A Systematic Review. Health Tech Asmnt Act, 2017, 1(1):e62068
2. Lohman D., Abidjanova N. Progress Update: Development of Palliative Care From 2017 to 2020 in Five Countries in Eurasia. Journal of Pain and Symptom Management, 2022, Vol. 64 №2.
3. Micke O., Seegenschmiedt M.H., Adamietz I.A., Kundt G., Fakhrian K., Schaefer U., Muecke R. German Cooperative Group on Radiotherapy for Nonmalignant Diseases (GCG-BD). Low-Dose Radiation Therapy for Benign Painful Skeletal Disorders: The Typical Treatment for the Elderly Patient? Int J Radiat Oncol Biol Phys, 2017, 15;98(4):958-963. doi: 10.1016/j.ijrobp.2016.12.012. Epub 2016 Dec 18. PMID: 28258900.
4. Ott O.J., Niewald M., Weitmann H.D., Jacob I., Adamietz I.A., Schaefer U., Keilholz L., Heyd R., Muecke R. German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD). DEGRO guidelines for the radiotherapy of non-malignant disorders. Part II: Painful degenerative skeletal disorders. Strahlenther Onkol, 2015, 191(1):1-6. doi: 10.1007/s00066-014-0757-3. Epub 2014 Sep 20. PMID: 25238992.
5. Palliative Care in Tajikistan. An emerging health service. London: eHospice, 2014. Available from http://www.ehospice.com/ArticleView/tabid/10686/ArticleId/11023/language/en-GB/Default.aspx. Accessed November 23, 2022.
6. Palmer A.L., Pearson M., Whittard P., McHugh K.E., Eaton D.J. Current status of kilovoltage (kV) radiotherapy in the UK: installed equipment, clinical workload, physics quality control and radiation dosimetry. Br J Radiol, 2016, 89(1068):20160641. doi: 10.1259/bjr.20160641. Epub 2016 Oct 12. PMID: 27730839; PMCID: PMC5604929.
7. Rosenblatt E., Fidarova E., Ghosh S., Zubizarreta E., Unterkirhere O., Semikoz N., Sinaika V., Kim V., Karamyan N., Isayev I., Akbarov K., Lomidze D., Bondareva O., Tuzlucov P., Zardodkhonova M., Tkachev S., Kislyakova M., Alimov J., Pidlubna T., Barton M, Mackillop W. Quality of radiotherapy services in post-Soviet countries: An IAEA survey. Radiother Oncol, 2018, 127(2):171-177. doi: 10.1016/j.radonc.2018.03.028. Epub 2018 Apr 25. PMID: 29705501.
8. Sánchez-Pérez J.L., Fuentes-Sánchez C., Acosta-Acosta B. Conjunctival-corneal intraepithelial neoplasia (Bowen disease) treated with orthovoltage. Cornea, 2011, 30(4):474-6. doi: 10.1097/ICO.0b013e3181dc816a. PMID: 21099419.
9. Thomas T.O., Agrawal P., Guitart J., Rosen S.T., Rademaker A.W., Querfeld C., Hayes J.P., Kuzel T.M., Mittal B.B. Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma. Int J Radiat Oncol Biol Phys, 2013, 85(3):747-53. doi: 10.1016/j.ijrobp.2012.05.034. Epub 2012 Jul 17. PMID: 22818412.
10. Trott K.R., Kamprad F. Estimation of cancer risks from radiotherapy of benign diseases. Strahlenther Onkol, 2006, 182(8):431-6. doi: 10.1007/s00066-006-1542-8. PMID: 16896588
11. Tsao M.N., Sinclair E., Assaad D., Fialkov J., Antonyshyn O., Barnes E. Radiation therapy for the treatment of skin Kaposi sarcoma. Ann Palliat Med, 2016, 5(4):298-302. doi: 10.21037/apm.2016.08.03. Epub 2016 Aug 25. PMID: 27701876.
12. Xu J., Yang E., Yu N.Z., Long X. Radiation Therapy in Keloids Treatment: History, Strategy, Effectiveness, and Complication. Chin Med J (Engl), 2017, 20;130(14):1715-1721. doi: 10.4103/0366-6999.209896. PMID: 28685723; PMCID: PMC5520560.
13. Zuenkova J., Izurov L. Forecasting the kilovoltage therapy unit. RAD Conf. Proc., 2020, vol. 4, pp. 7–10.
14. Zuenkova Yu. A. Analysis of the Technical Characteristics of X-Ray Therapy Systems and the Potential for Their Further Improvement. Biomedical Engineering, 2022, Vol. 55, No. 5, pp. 370-374.
Review
For citations:
Zuenkova Yu.A. Analysis and modeling for calculation the need for x-ray therapy systems in Tajikistan. Herald of the medical and social institute of Tajikistan. 2022;(4):27-33. (In Russ.)
Views:
37
Email this article 